IMNM
Immunome, Inc.
NASDAQ · USHealthcareBiotechnology
$22.12-0.90%
Price as of Jul 20, 2026
IMNM ownership
Immunome, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
3/100
Buys (3m)
4
Sells (3m)
13
Net (3m)
-$10.1M
Insiders buying
Insider trades by month Buys Sells
Dec
Mar
Apr
May
Jun
Jul
Context3-month price +6.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Barchas Isaacdirector | Sell | 16,906 | $24.20 |
| Jul 7, 2026 | Barchas Isaacdirector | Sell | 83,094 | $24.11 |
| Jul 7, 2026 | Lechleider Robertofficer: Chief Medical Officer | Sell | 16,072 | $23.44 |
| Jul 7, 2026 | Lechleider Robertofficer: Chief Medical Officer | Sell | 16,214 | $22.76 |
| Jul 7, 2026 | Lechleider Robertofficer: Chief Medical Officer | Sell | 22,714 | $21.95 |
| Jul 7, 2026 | Lechleider Robertofficer: Chief Medical Officer | Option | 55,000 | $8.73 |
| Jul 2, 2026 | Barchas Isaacdirector | Sell | 24,335 | $23.33 |
| Jul 2, 2026 | Barchas Isaacdirector | Sell | 101,050 | $21.12 |
| Jul 2, 2026 | Barchas Isaacdirector | Sell | 75,665 | $22.35 |
| Jun 29, 2026 | Lechleider Robertofficer: Chief Medical Officer | Option | 55,000 | $8.73 |
| Jun 29, 2026 | Lechleider Robertofficer: Chief Medical Officer | Sell | 40,580 | $19.56 |
| Jun 29, 2026 | Lechleider Robertofficer: Chief Medical Officer | Sell | 14,420 | $20.66 |
| Jun 17, 2026 | Rosett Maxofficer: Chief Financial Officer | Option | 60,000 | $1.05 |
| Jun 17, 2026 | Rosett Maxofficer: Chief Financial Officer | Sell | 60,000 | $18.23 |
| Jun 12, 2026 | BIENAIME JEAN JACQUESdirector | Grant | 9,897 | $18.16 |
| Jun 12, 2026 | WAGENHEIM PHILIPdirector | Grant | 9,897 | $18.16 |
| Jun 12, 2026 | Boylan James Pdirector | Grant | 9,897 | $18.16 |
| Jun 12, 2026 | Barchas Isaacdirector | Grant | 9,897 | $18.16 |
| Jun 12, 2026 | SCHAFER CAROLdirector | Grant | 9,897 | $18.16 |
| Jun 12, 2026 | SWAIN SANDRA Mdirector | Grant | 9,897 | $18.16 |
| Jun 9, 2026 | BIENAIME JEAN JACQUESdirector | Buy | 3,500 | $19.46 |
| Jun 9, 2026 | BIENAIME JEAN JACQUESdirector | Buy | 1,000 | $19.27 |
| Jun 9, 2026 | BIENAIME JEAN JACQUESdirector | Sell | 500 | $19.44 |
| Jun 9, 2026 | BIENAIME JEAN JACQUESdirector | Sell | 10,000 | $19.41 |
| Jun 9, 2026 | BIENAIME JEAN JACQUESdirector | Buy | 6,000 | $19.48 |
| May 19, 2026 | BIENAIME JEAN JACQUESdirector | Buy | 5,000 | $20.70 |
| Apr 3, 2026 | Rosett Maxofficer: Chief Financial Officer | Sell | 1,344 | $22.48 |
| Apr 3, 2026 | Rosett Maxofficer: Chief Financial Officer | Sell | 63,656 | $21.91 |
| Apr 3, 2026 | Rosett Maxofficer: Chief Financial Officer | Option | 39,713 | $1.35 |
| Apr 3, 2026 | Rosett Maxofficer: Chief Financial Officer | Option | 31,848 | $1.05 |
Source: IMNM SEC Form 4 filings, latest Jul 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their IMNM positions over the last 6 months (SEC Form 13F).
Increased
152
New positions
90
Reduced
85
Sold out
60
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 17.0M | May 15, 2026 |
| FMR LLC | Increased | 16.5M | Feb 17, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 16.4M | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 13.4M | Feb 19, 2026 |
| BLACKROCK, INC. | Increased | 8.2M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 7.6M | Feb 12, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 7.0M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 6.0M | Jan 29, 2026 |
| REDMILE GROUP, LLC | Increased | 5.7M | Feb 17, 2026 |
| REDMILE GROUP, LLC | Reduced | 5.6M | May 15, 2026 |
| STATE STREET CORP | Increased | 5.4M | May 15, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 4.8M | May 11, 2026 |
| ENAVATE SCIENCES GP, LLC | Unchanged | 4.8M | Feb 17, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4.7M | May 15, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 4.7M | Feb 11, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.